µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º h7eb/xEto
2?qT,pN
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ 0=+feB1T
V1,p<>9
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) SOPair <r
zSA"f_e
1. ICAM-1 #+<YFm\i
zZd.
U\"2
2. interleukin 12(IL-12) bRggt6$z
d v4~CW%Td
3. tumor infiltrating lymphocyte E
6#/@C,
BJ_"FG
4. TCR/CD3 complex C6g p}%
i\uj>;B
5. hematopoietin receptor family K:13t
|
k^d^Todq.
6. individual idiotype(IdI) O:'qwJ#~
J>M 9t%f@
7. integrin leF!Uog
du0o4~-
8. colony-stimulatory factor (CSF) w3VgGc~
d %FLk=]
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© rosD)]I7
2xUgM}e
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? ?c8(<_I+
Xhyn! &H5
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ Jza?DhSAZ
TC2%n\
GH*
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠp,f$9t4
ukVBC"Ny
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ `<P:ly.
Cb|1Jtb
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) 3mopTzs)
Y~!A"$
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ $!$If(
7
} 7:T?
`V:
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) }/\`'LQ
h-O;5.m-P
3. immunoglobulin superfamily (IgSF) 9
!UNO
q$b4S4Z7
4. selectin 3b#L*-
?F!c"+C
5. anti-idiotypic antibody (¦ÁId) q7_Ttjn-DV
/:{4,aX2
6. major histocompatibility complex(MHC) <}'=@a
SO
STtuT
7. immunotolerance bWlYQ
=-r); d
8. biological reponse modifier(BRM) f9},d1k
NOkgG0Z
9. immune reponse gene (Ir gene) %,<Ki]F
h
6?Z
10. reshaped antibody (or reconstituted antibody) M=&,+#z<V
6rD]6#D
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© }(XKy!G6
3iX\):4
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£
uM,Ps}
-r3
s{HO
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? P7Qel ,
Y.tT#J^=
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ QX<x2U
bX:h"6{=R
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? Ar,n=obG
}P{Wk7#Jq
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ O1t$]k:
-TG ="U
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? ~7*2
Jp'
hLk6Hqr7
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ ,5ZQPICF
0jjtx'F
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ :E~rve'
b l+g7 g;
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? 7 [u>#8
p)?6#~9$
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ y5+%8#3
7C3YVm6g
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: 2ag8?#
P#XV_2
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: S 593wfc
Iapz,nuE
̉񧄤
<9yh:1"X
p@4GI[ 4
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 51#OlvD
A(
vdlj
1. CD8 )hj:Xpj9#
je2_.^
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) 1nskf*Z
*pS 7,Hm
3. immunoglobulin fold(Ig fold)
G7al@
l&qCgw
4. cadherin (Ca-dependent cell adhesion moleculers) N~mr@rXC
z"UC$
5. idiotype-anti-idiotypic antibody immune network theory /+SLq`'u)
B<m0YD?>~>
6. HLA class II antigen S\&3t}_
ty0P9.Q
7. complementarity-determining region (CDR) U"p</
Q
<c pc
k
8. perforin(or pore-forming protein ,PFP) PKSfu++Z
4Qfsxg
9. high affinity IL-2 receptor l_+@Xpl
gK[;"R)4o@
10. artificial active immunization mSxn7LG
TD}<U8I8_
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© _q27
3QG/"
hb5K"9Y
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ1I9v`eT4
S v>6:y9?G
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 -o6rY9\_!
!-f Bw
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ @ivd|*?k0
d7X&3L%Oq
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ `R[ZY!=+
[s{
!
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ (G>[A}-
e yJ07
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? 5:h[%3'bB
WKEb
'^
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ]yU"J:/
%X{Eupi
FA
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ d,"LZ>hNY*
`Z?wj@H1`
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ Ic#xz;elM
DZ8|20b
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ kz"uTJK
'x!\pE-
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© x%G3L\5
??rS h Mu
1. immunoglobulin gene rearrangement ?['!0PF
&_ekA44E
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) a:h<M^n049
I{`7 0
3. flow cytometry(FCM) S\k <
X
W)TI
4. carrier effect Bh>L"'.2
dj0; tQ=C
5. positive selection of T lymphocytes in thymus 7 F^d-
~C.*Vc?|
6. mouse TH1(Th1) and TH2(Th2) subsets \N>
-+r
'X`Z1L/
7. perforin (pore-forming protein ,PFP) Lsmcj{1d
)*,/L <
8. ADCC(antibody-dependent cell-mediated cytotoxicity) aER|5!7(2\
<qCa9@Ea
9. SH-2(src-homology region 2) DX>a0-Xj
H"Pb)t
10. Ab2¦Â (internal image) h~MV=7
lE
=8kmFXo
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© )s2] -n}W
WL$^B@gXQ
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? L"L3n,%F
YdY-Jg Xm
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? E-MPFL
+Q*`kg'
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦ÓᣠTBh
M^\z
e_vsiT
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ bQll;U^A
]6&NIz`:,
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠZSMed(//b
MfTLa)Rz
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) Otn,UoeeB
R+sT
&d
ÃâÒßѧרҵ£º 4 p_C+4
y>{:[L9*
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ \?:L>-&h8
*P()&}JK
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? ?5|;3N/zt
Ur j*V0^
´«È¾²¡Ñ§×¨Òµ£º 2`yhxO
NGra/s,9|
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ h@)U,&
xQ?>72grP
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£
D+8d^-:
[^>XRBSm
Ïû»¯×¨Òµ£º Hg+<GML
Nk~}aj
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ LvG.ocCG
Z['.RF'`
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ?
^5 >e
4Z)4WGp!
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ w+o5iPLX
Tw~R-SiS`s
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© >T$0*7wF
Z[vx0[av&
1. Fas(CD95)/FasL #ydold{F
[hJ1]RW8
2. common chain of cytokine receptor /iW+<@Mas
,CE/o7.FG
3 . TCR/CD3 complex l,ny=Q$[1'
AbU`wr/h 4
4. negaive selection of thymocytes %V_ XY+o
D{9a'0J
5. artificial active immune uH_KOiF
z%&FLdXgW+
6. anti-idiotypic AR"2?2<mJ7
w,~*ead
7. IgSF D#jwI,n}x
b[%@3 }E
8. Integrin e8,_"_1:F
uJ`N'`Z
9. chemokine /4{WT?j
EPo)7<|>
10. B7/CD28 7uB
x
g&RpE41x
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© o)Q4+njT@
P0N/bp2Uy
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ Z;+,hR ((
2[
sY?C
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ z/Lb1ND8
V[ UOlJ
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ as07~Xvp-
%<i sdvF
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ vuQA-w7
$G=^cNB|JB
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ / Pjd"
^Ks1[xc* `
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ 4vg,g(qi<
dJ"44Wu+J
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© DVQr7tQf
? [Yn<|
1. B7/CD28 o HK
fb
f
&bJT
2. Th1 subset 8%4;'[UV
SiNgV\('U
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© h]zok}$
lh-.I]>&`
4. antibody affinity maturation q\tr&@4iC
a-*sm~u
5. AP-1 NbWEP\dS'z
hyxv+m[
6. single chain variable fragment£¨ScFv£© Jq1oQu|rs
#m#IBRD :
7. NK cell receptor G-CL \G\n
,]wab6sY
8. Zinkernagel-Doherty phenomenon hn .(pI1
<B%wq>4S
9. Ig fold 03?ADjO
ImQ-kz?b
10. CD40/CD40L 5REH`-
5nc
W
s)
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© Gn7\4,C
*b;)7lj0h
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ hl[<o<`Q
-raK
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ ]:ca=&>
Sh;`<Ggi~
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ :qS~"@ ?<
g=KK
PSK
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ l="(Hp%b
2
SU'lh\E
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ 2 U%t
!B[Y?b:
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ B
l)D/
)1 @v<I
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ r:xg#&"*
Jv(E'"H
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© ~+6#4<M.~
jKP75jm
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© :wzbD,/M
6
y"r'
1.Co-stimulators (or co-stimulating molecules) 5m;pHgkb
>yyu:dk-;
2.NK-kB sS)tSt{C
qq^[(n
3.Immunoglobulin superfamily F0m[ls$
?h7[^sxJ
4.antigen-presenting cell (APC) Ty 6 XU!
"{{@N4^
5.death domain Ux,dj8=o
PHsM)V+
6.CCR and CXCR DL_M#c`<
X7aj/:fXe
7.Lectin (or mitogen) */]1?M@P)
4[0.M
8.Clusters of differentiation, CD)
?s 0")R&
)P/~{Ci:T&
9.B7 family [o'}R`5)
v|kL7t)}
10.Cytotoxic T lymphocyte, CTL)
wZ8LY;
%D^j7`Z
11.IL-15 and IL-15 receptor (IL-15R)
(+\K
piUfvw
12.MHC restriction avv/mEf-f
TwE&5F*
13.Affinity-chromatography [h
:FJ
1n
ZE9;o
14.Cyctosprin A, CsA _`94CC:
hWu#}iN
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) p4zV<qZ>e
"_&HM4%!
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© -aMwC5iR@
M#>f:_`<
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 dv\oVD
(aH_K07
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ q}R"
DU4Prjb'
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ 4~r=[|(aY
hMs}r,*
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© 7"
cgj#
Ts:pk
ÃâÒßѧרҵ£º 2\!.w^7'^T
PFIL)D
|G
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ p>p=nL K
ffyKAZ{]po
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ W,>;`>
MhB kr{8
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ Lp/]iZ@
A]vQ1*pnk
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) Z,,Wo
%
)o
[XQoag;!
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) c>3W1"
GRj{*zs
1. ADCC(antibody dependent cell-mediated cytotoxicity) S*CRVs
^f1}:g
2. »·æß¾úËØ(cyclosporin) @,sg^KB
p<6pmW3
3. KIR(killer cell inhibitory receptor) TaB35glLY
.x1EdfHed/
4. HLDA(human leucocyte differentiation antigen) (F7!&] 8%
n4CzReG
5. Interleukin 18(IL-18) !=0N38wA
Xf9VW}`*8
6. ÕûºÏËØ(integrin) $X-,6*
;LH?Qu;e
7. Fas/FasL 8F4#E
U
12E@9s$Z
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) %-T]!3"n
E(
*$wD
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) r0j:ll d
K |Yr
10. Th1/Th2 v?h#Ym3e<
M6|Q~8$
11. »ùÒòÒßÃç(DNAÒßÃç) K#F~$k|1B
G*wn[o(^j
12. chemokines and chemokine receptor **0Y*Ax@
kRE^G*?
13. ÃâÒßÄÍÊÜ 9[6*FAFJPP
<h7C_^L10\
14. ¹²´Ì¼¤·Ö×Ó HcQ{ok9u
eVbHPu4
15. ËÀÍö½á¹¹Óò(death domain) +69sG9BA
<r3F*S=
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) O,xU+j~)
i':<